Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
11/04/2004 | US20040220207 Chemokine receptor binding heterocyclic compounds |
11/04/2004 | US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants |
11/04/2004 | US20040220201 Tyrosine kinase inhibitors |
11/04/2004 | US20040220200 Compositions useful as protein kinase inhibitors |
11/04/2004 | US20040220196 antitumor agents; 4-amino-5-fluoro-3-(6-( 4-methylpiperazin-1-yl)1H-benzimidazol-2-yl)-quinolin-2-one |
11/04/2004 | US20040220195 Antibiotic P175-A and semisynthetic derivatives thereof |
11/04/2004 | US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound |
11/04/2004 | US20040220192 antiserotonine agents; central nervous system disorders; anxiolytic agents; attention deficit disorders; strokes; headaches |
11/04/2004 | US20040220191 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
11/04/2004 | US20040220188 Alkylidene pyrazolidinedione derivatives |
11/04/2004 | US20040220185 antiinflammatory agents; antiarthritic agents; anticancer agents |
11/04/2004 | US20040220183 inhibiting tumor necrosis factor; respiratory system disorders; prevent neutrophil infiltration in lungs; skin disorders |
11/04/2004 | US20040220180 Compositions relating to novel compounds and targets thereof |
11/04/2004 | US20040220177 Anticancer agents |
11/04/2004 | US20040220174 for example, 1-(4-methoxyphenyl)-7-oxo-6-[5-(2-oxo-1-piperidinyl)2-pyridinyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide; use as anticoagulant agent for treatment of thromboembolic disorders |
11/04/2004 | US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
11/04/2004 | US20040220171 anticoagulants; immunomoderators; antiinflammatory agents |
11/04/2004 | US20040220170 analgesics; reduction of pain |
11/04/2004 | US20040220169 anticoagulants; factor x inhibitor; N-[1-(5-chloro-1H-benzimidazol-2-yl)ethyl]-3-methyl-4-(2,5-dihydropyrrol-1-ylcarbonyl)benzamide |
11/04/2004 | US20040220112 administering 2-(N-Methylsulfonamido-2-aminophenyl)-N-methyl-N-[(1S)-1-phenyl-2-(1-pyrrolidinyl)ethyl]acetamide as an anti-pruritic agent; antihyperalgesics; analgesics; central nervous system side effect reduction |
11/04/2004 | US20040219686 Methods and mixtures pertaining to analyte determination |
11/04/2004 | US20040219685 Using mass analysis to monitor concentration of analytes in fluids; electrophilic and chromatographic separation |
11/04/2004 | CA2526897A1 4-anilino-quinazoline derivatives as antiproliferative agents |
11/04/2004 | CA2523062A1 5-hydroxyindoles with n-oxide groups and use thereof as a phosphodiesterase 4 inhibitor |
11/04/2004 | CA2523048A1 4-, 6- o 7-hydroxyindoles having n-oxide groups and the use thereof as therapeutic agents |
11/04/2004 | CA2522803A1 Substituted pyrimidinones and pyrimidinthiones as crf antagonists |
11/04/2004 | CA2522682A1 Indazole derivatives as jnk inhibitors |
11/04/2004 | CA2522667A1 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
11/04/2004 | CA2522562A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
11/04/2004 | CA2522536A1 Five-membered heterocyclic derivative |
11/04/2004 | CA2518839A1 (piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-ht1f agonists |
11/03/2004 | EP1472252A1 Substituted fused pyrazolecarboxylic acid arylamides and related compounds |
11/03/2004 | EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3 |
11/03/2004 | EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
11/03/2004 | EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins |
11/03/2004 | EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide |
11/03/2004 | EP1472230A2 Ansamycins having improved pharmacological and biological properties |
11/03/2004 | EP1472226A1 Heterocyclic amide compounds as apolipoprotein b inhibitors |
11/03/2004 | EP1472225A2 2-piperazine-pyridines useful for treating pain |
11/03/2004 | EP1472223A1 Gamma secretase inhibitors |
11/03/2004 | EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases |
11/03/2004 | EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain |
11/03/2004 | EP1472216A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
11/03/2004 | EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors |
11/03/2004 | EP1471916A2 Treatment of rheumatoid arthritis using imatinie |
11/03/2004 | EP1471915A2 2,4-pyrimidinediamine compounds and their uses |
11/03/2004 | EP1471911A1 Novel crystalline forms of gatifloxacin |
11/03/2004 | EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors |
11/03/2004 | EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
11/03/2004 | EP1471786A1 Microbiocidal n-phenyl-n- 4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
11/03/2004 | EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors |
11/03/2004 | EP1232153B1 Imidazole derivatives and their use as raf kinase inhibitors |
11/03/2004 | EP1206452B1 Novel method for preparing benzoperhydroisoindole compounds |
11/03/2004 | EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors |
11/03/2004 | EP1169338B1 Low-molecular inhibitors of complement proteases |
11/03/2004 | EP1114117B1 Electrochromic device with a yellow filter |
11/03/2004 | EP0942906B1 Compounds useful for inhibition of farnesyl protein transferase |
11/03/2004 | CN1543465A Novel heterocyclic compounds as selective bacterial DHFR inhibitors and their uses thereof |
11/03/2004 | CN1543461A Melanocortin receptor ligands |
11/03/2004 | CN1543460A Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |
11/03/2004 | CN1543459A Quinoline derivatives and quinazoline derivatives having azolyl group |
11/03/2004 | CN1543455A 3-phenoxy-4-pyridazinol derivative and herbicide composition containing the same |
11/03/2004 | CN1543346A Novel compounds |
11/03/2004 | CN1542002A Inhibitors of metalloproteinase, pharmaceutical compositions containing them, their pharmaceutical application and methods and intermediate compounds for their preparation |
11/03/2004 | CN1542001A Small molecule inhibitors of rotamase enzyme activity |
11/03/2004 | CN1173972C Azaring-ether derivatives and their use as nicotinic ach receptor modulators |
11/03/2004 | CN1173971C Cycloalkyl-substituted aminomethylpyrrolidine derivatives |
11/03/2004 | CN1173970C Tetrahydroquinoline derivatives as glycine antagonists |
11/03/2004 | CN1173953C Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
11/03/2004 | CN1173951C Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
11/03/2004 | CN1173950C 2,3-Disubstituted pyridine derivatives, process for preparation thereof, drug compositions containing the same and intermediates for preparation |
11/03/2004 | CN1173946C Method for preparing an N-[(aliphatic or aromatic) carbonyl]-2-aminoacetamide compound and a cyclyzed compound |
11/02/2004 | US6812344 1-(4-Arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximidoL)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
11/02/2004 | US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments |
11/02/2004 | US6812243 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
11/02/2004 | US6812235 2-acylamino- beta -alanine derivatives and a pharmaceutically acceptable salt, useful as fibrinogen receptor antagonists |
11/02/2004 | US6812231 Inhibiting activated blood-coagulation factor x |
11/02/2004 | US6812226 For therapy of rheumatoid arthritis, effecting immunosuppression |
11/02/2004 | US6812225 Pyschological disorders; antidepressants |
11/02/2004 | CA2320676C Process and intermediates for the preparation of aminotriazine derivatives |
11/02/2004 | CA2315614C Pyrazoles |
11/02/2004 | CA2296313C 2-aminopyridines containing fused ring substituents as nos inhibitors |
11/02/2004 | CA2282279C Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions |
10/28/2004 | WO2004092196A2 Tie-2 modulators and methods of use |
10/28/2004 | WO2004092168A1 Cgrp receptor antagonists |
10/28/2004 | WO2004092166A2 Cgrp receptor antagonists |
10/28/2004 | WO2004092164A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
10/28/2004 | WO2004092158A1 Carboxamide derivatives as anti-diabetic agents |
10/28/2004 | WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators |
10/28/2004 | WO2004092144A2 Quinazoline compounds useful as p38 kinase inhibitors |
10/28/2004 | WO2004092140A1 Biaryl substituted pyrazoles as sodium channel blockers |
10/28/2004 | WO2004092130A2 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
10/28/2004 | WO2004092124A2 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
10/28/2004 | WO2004091610A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
10/28/2004 | WO2004091542A2 Nitrogen containing integrin targeting compounds |
10/28/2004 | WO2004091518A2 Cxcr4 chemokine receptor binding compounds |
10/28/2004 | WO2004091514A2 Cgrp receptor antagonists |
10/28/2004 | WO2004091485A2 Aminoquinoline compounds |
10/28/2004 | WO2004091480A2 Tie-2 modulators and methods of use |
10/28/2004 | WO2004080461A3 Stable pharmaceutical compositions of desloratadine |